Author:
Fedeli Ugo,Alba Natalia,Schievano Elena,Visentin Cristiana,Rosato Rosalba,Zorzi Manuel,Ruscitti Giancarlo,Spolaore Paolo
Abstract
Abstract
Background
Several previous studies conducted on cancer registry data and hospital discharge records (HDR) have found an association between hospital volume and the recourse to breast conserving surgery (BCS) for breast cancer. The aim of the current study is to depict concurrent time trends in the recourse to BCS and its association with hospital volume.
Methods
Admissions of breast cancer patients for BCS or mastectomy in the period 2000–2004 were identified from the discharge database of the Veneto Region (Italy). The role of procedural volume (low < 50, medium 50–100, high > 100 breast cancer surgeries/year), and of individual risk factors obtainable from HDR was assessed through a hierarchical log-binomial regression.
Results
Overall, the recourse to BCS was higher in medium (risk ratio = 1.12, 95% confidence interval 1.07–1.18) and high-volume (1.09, 1.03–1.14) compared to low-volume hospitals. The proportion of patients treated in low-volume hospitals dropped from 22% to 12%, with a concurrent increase in the activity of medium-volume providers. The increase over time in breast conservation (globally from 56% to 67%) was steeper in the categories of low- and medium-volume hospitals with respect to high caseload.
Conclusion
The growth in the recourse to BCS was accompanied by a decline of the association with hospital volume; larger centers probably acted as early adopters of breast conservation strategies that subsequently spread to smaller providers.
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente C, De Lena M, Gallus G, Greco M, Luini A, Marubini E, Muscolino G, Rilke F, Salvadori B, Zecchini A, Zucali R: Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981, 305: 6-11.
2. NIH Consensus Conference: Treatment of early-stage breast cancer. JAMA. 1991, 265: 391-395. 10.1001/jama.265.3.391.
3. Morrow M, Bucci C, Rademaker A: Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg. 1998, 186: 269-274. 10.1016/S1072-7515(97)00153-1.
4. Lazovich D, Solomon CC, Thomas DB, Moe RE, White E: Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer. 1999, 86: 628-637. 10.1002/(SICI)1097-0142(19990815)86:4<628::AID-CNCR11>3.0.CO;2-L.
5. Hebert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschenes L: Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994. CMAJ. 1999, 161: 951-955.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献